|  |  |  | Age ≥6 years |  | Age <6 years |  |
---|---|---|---|---|---|---|---|
 | All | Standard | Intensified | Standard | Intensified | Standard | Intensified |
All | 70 | 37 | 33 | 27 (57) | 20 (43) | 10 (43) | 13 (57) |
Female | 35 | 21 (57) | 14 (42) | 14 (52) | 9 (45) | 7 (78) | 5 (42) |
Age (years), participants ≥6 years | 37 (28–48) | 37 (28–48) | 37 (30–46) | 38 (29–50) | 38 (31–46) | n/a | n/a |
Age (months), participants <6 years | 16 (6–22) | 21 (5–47) | 11 (6–19) | n/a | n/a | 21 (5–47) | 10.5 (6–18) |
Enrolled from outpatient | 4 (6) | 1 (3) | 3 (9) | 1 (4) | 3 (15) | 0 | 0 |
Days ill prior to enrollment | 21 (16–60) | 30 (20–60) | 21 (14–44) | 45 (30–60) | 21 (14–60) | 14 (12–17) | 20 (14–36) |
Fever | 52 (74) | 27 (73) | 25 (76) | 19 (70) | 13 (65) | 8 (80) | 12 (92) |
Cough | 68 (97) | 35 (95) | 33 (100) | 27 (100) | 19 (95) | 9 (90) | 13 (100) |
Weight loss | 45 (64) | 22 (60) | 23 (70) | 17 (63) | 16 (80) | 5 (50) | 7 (54) |
Night sweats | 21 (30) | 10 (27) | 11 (33) | 10 (37) | 6 (20) | 1 (10) | 4 (31) |
Clinical suspicion extrapulmonary TB | 3 (4) | 2 (5) | 1 (3) | 2 (7) | 1 (5) | 0 | 0 |
Chest radiograph suspect TB*†| 31 (50) | 19 (51) | 12 (41) | 15 (56) | 9 (45) | 3 (30) | 4 (30) |
Chest infiltrates, no other suspicious features | 19 (31) | 8 (24) | 11 (38) | 4 (15) | 5 (20) | 7 (60) | 3 (23) |
Previously treated for TB | 4 (6) | 3 (8) | 1 (3) | 3 (11) | 1 (5) | 0 | 0 |
Malnourished** | 39 (56) | 20 (54) | 19 (58) | 15 (56) | 11 (55) | 5 (50) | 8 (62) |
HIV infection | 34 (49) | 15 (41) | 19 (58) | 13 (48) | 13 (65) | 2 (20) | 6 (46) |
<12 months since HIV diagnosis†‡ | 28 (82) | 15 (100) | 13 (68) | 8 (30) | 13 (100) | 1 (50) | 5 (83) |
Antiretroviral therapy at enrollment†| 13 (38) | 5 (33) | 8 (42) | 4 (15) | 7 (35) | 1 (50) | 1 (17) |
CD4+ cell count/mm3‡ | 180 (10–405) | 172 (17–293) | 180 (9–578) | 172 (15–291) | 19 (8–229) | n/a | n/a |
CD4+ cell percentage‡ | 0.9 (0.2–16) | 0.5 (0.2–21) | 0.9 (0.2–16) | n/a | n/a | 23 (0.5-45) | 16 (8–30) |